Hui Zhang
- Immunology top 0.5%
- Immune Cell Function and Interaction 33
- Immune cells in cancer 29
- Atherosclerosis and Cardiovascular Diseases 19
- Immune Response and Inflammation 18
- Cancer Research top 2%
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research 20
- Nephrology top 2%
- Biological Psychiatry top 5%
-
- Inflammasome and immune disorders 23
- Bone Metabolism and Diseases 17
-
- Cancer Immunotherapy and Biomarkers 15
- Co-authors
- Jörg J. GoronzyCornelia M. WeyandRyu WatanabeGerald J. BerryNiansheng YangYuefang HuangTony Wyss‐CorayJijun Zhao
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (1 paper)Circulation (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui Zhang
298 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Immunology 2.9k
- Cancer Research 840
- Rheumatology 791
- Nephrology 361
- Biological Psychiatry 127
Countries citing papers authored by Hui Zhang
This map shows the geographic impact of Hui Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Zhang more than expected).
Fields of papers citing papers by Hui Zhang
This network shows the impact of papers produced by Hui Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Zhang. The network helps show where Hui Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 5 | |
| 14 | Protective Effect of Crocin on Immune Checkpoint Inhibitors-Related Myocarditis Through Inhibiting NLRP3 Mediated Pyroptosis in Cardiomyocytes via NF-κB Pathway | 2022 | 30 |
| 15 | 2022 | 17 | |
| 16 | 2020 | 169 | |
| 17 | 2019 | 2 | |
| 18 | 2019 | 10 | |
| 19 | 2018 | 26 | |
| 20 | Activation of the PI3K/Akt pathway is essential for the survival of Brucella melitensis 16 M in vitro and in vivo. | 2015 | 4 |
About Hui Zhang
Hui Zhang is a scholar working on Immunology, Nephrology and Rheumatology, having authored 310 papers that have together received 8.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (33 papers), Immune cells in cancer (29 papers), Inflammasome and immune disorders (23 papers), Systemic Lupus Erythematosus Research (20 papers), Atherosclerosis and Cardiovascular Diseases (19 papers), Immune Response and Inflammation (18 papers), Bone Metabolism and Diseases (17 papers) and Cancer Immunotherapy and Biomarkers (15 papers). The work is most often cited by research in Immunology (2.9k citations), Cancer Research (840 citations) and Rheumatology (791 citations). Hui Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jörg J. Goronzy, Cornelia M. Weyand, Ryu Watanabe, Gerald J. Berry, Niansheng Yang, Yuefang Huang, Tony Wyss‐Coray, Jijun Zhao, Gary G. Meadows and Hongyue Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.